Kezar Life Sciences, Inc. — Director's Dealing 2019

Jan 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2019-01-06

Reporting Person: Kirk Christopher J. (Director, President and CSO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-06	Employee Stock Option (right to buy)	$22.85	A	87500	Acquired	2029-01-05	Common Stock (87500)	Direct

Footnotes

F1: One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 6, 2019, subject to the Reporting Person continuing to provide service through each such date.